IVIG is recommended as first-line treatment of for MMN.
Initial dose: 2 g/kg divided over 2 to 5 days.
Maintenance dose: tailor to the lowest dose that maintains clinical efficacy, usually 1g/kg or less per treatment course.
Some patients may require higher doses for efficacy, up to 2 g/kg every 4 weeks.